Article info
PDFBrief report
Oral nicotine marketing claims in direct-mail advertising
- Correspondence to Dr Minal Patel, Schroeder Institute, Truth Initiative, Washington, DC, USA; mpatel{at}truthinitiative.org
Citation
Oral nicotine marketing claims in direct-mail advertising
Publication history
- Received December 21, 2020
- Revised March 10, 2021
- Accepted March 17, 2021
- First published May 6, 2021.
Online issue publication
November 15, 2022
Article Versions
- Previous version (15 November 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.